334 related articles for article (PubMed ID: 11980061)
1. The neurobiology of narcolepsy-cataplexy syndrome.
Aldrich MS
Int J Neurol; 1991-1992; 25-26():29-40. PubMed ID: 11980061
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
Nishino S; Kanbayashi T
Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
[TBL] [Abstract][Full Text] [Related]
3. [Wake disorders. I. Primary wake disorders].
Billiard M; Carlander B
Rev Neurol (Paris); 1998 Feb; 154(2):111-29. PubMed ID: 9773032
[TBL] [Abstract][Full Text] [Related]
4. Narcolepsy: genetic predisposition and neuropharmacological mechanisms. REVIEW ARTICLE.
Nishino S; Okura M; Mignot E
Sleep Med Rev; 2000 Feb; 4(1):57-99. PubMed ID: 12531161
[TBL] [Abstract][Full Text] [Related]
5. [Narcolepsy].
Billiard M; Cadilhac J
Rev Neurol (Paris); 1985; 141(8-9):515-27. PubMed ID: 2868518
[TBL] [Abstract][Full Text] [Related]
6. Perspectives in narcolepsy research and therapy.
Mignot E
Curr Opin Pulm Med; 1996 Nov; 2(6):482-7. PubMed ID: 9363189
[TBL] [Abstract][Full Text] [Related]
7. Childhood onset of narcolepsy-cataplexy syndrome in Turkey: clinical and genetic study.
Pelin Z; Bozluolcay M; Kaynak D; Kaynak H
Turk J Pediatr; 2002; 44(4):321-5. PubMed ID: 12458808
[TBL] [Abstract][Full Text] [Related]
8. [Neurodegenerative, autoimmune and genetic processes of human and animal narcolepsy].
Dauvilliers Y
Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S83-7. PubMed ID: 14646805
[TBL] [Abstract][Full Text] [Related]
9. Development of cataplexy in genetically narcoleptic Dobermans.
Riehl J; Nishino S; Cederberg R; Dement WC; Mignot E
Exp Neurol; 1998 Aug; 152(2):292-302. PubMed ID: 9710528
[TBL] [Abstract][Full Text] [Related]
10. Narcolepsy and the hypocretins.
Wurtman RJ
Metabolism; 2006 Oct; 55(10 Suppl 2):S36-9. PubMed ID: 16979425
[TBL] [Abstract][Full Text] [Related]
11. The clinical spectrum of narcolepsy with cataplexy: a reappraisal.
Sturzenegger C; Bassetti CL
J Sleep Res; 2004 Dec; 13(4):395-406. PubMed ID: 15560774
[TBL] [Abstract][Full Text] [Related]
12. Sleepiness that cannot be overcome: narcolepsy and cataplexy.
Han F
Respirology; 2012 Nov; 17(8):1157-65. PubMed ID: 22471619
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetics and treatment of narcolepsy.
Dauvilliers Y; Tafti M
Ann Med; 2006; 38(4):252-62. PubMed ID: 16754256
[TBL] [Abstract][Full Text] [Related]
14. Studies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602-positive narcoleptic subjects with cataplexy.
Black JL; Silber MH; Krahn LE; Avula RK; Walker DL; Pankratz VS; Fredrickson PA; Slocumb NL
Biol Psychiatry; 2005 Sep; 58(6):504-9. PubMed ID: 16043129
[TBL] [Abstract][Full Text] [Related]
15. Narcolepsy.
Aldrich MS
Neurology; 1992 Jul; 42(7 Suppl 6):34-43. PubMed ID: 1630637
[TBL] [Abstract][Full Text] [Related]
16. HLA-DQB1 genotyping in a family with narcolepsy-cataplexy.
Pedrazzoli M; Pontes JC; Peirano P; Tufik S
Brain Res; 2007 Aug; 1165():1-4. PubMed ID: 17658488
[TBL] [Abstract][Full Text] [Related]
17. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients.
Mignot E; Hayduk R; Black J; Grumet FC; Guilleminault C
Sleep; 1997 Nov; 20(11):1012-20. PubMed ID: 9456467
[TBL] [Abstract][Full Text] [Related]
18. Narcolepsy and depression and the neurobiology of gammahydroxybutyrate.
Mamelak M
Prog Neurobiol; 2009 Oct; 89(2):193-219. PubMed ID: 19654034
[TBL] [Abstract][Full Text] [Related]
19. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate].
Poza-Aldea JJ
Rev Neurol; 2009 Jan 1-15; 48(1):27-31. PubMed ID: 19145563
[TBL] [Abstract][Full Text] [Related]
20. Association of HLA-DR and -DQ genes with narcolepsy in Koreans: comparison with two control groups, randomly selected subjects and DRB1*1501-DQB1*0602--positive subjects.
Roh EY; Park MH; Park H; Park DH; Choi JB; Kim SJ; Jeong DU
Hum Immunol; 2006 Sep; 67(9):749-55. PubMed ID: 17002906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
